Search hospitals > Louisiana > Baton Rouge
Pennington Biomedical Research Center
Claim this profileBaton Rouge, Louisiana 70808
Global Leader in Obesity
Global Leader in Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Insulin Resistance
Conducts research for Childhood Obesity
301 reported clinical trials
10 medical researchers
Summary
Pennington Biomedical Research Center is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Obesity, Diabetes, Type 2 Diabetes, Insulin Resistance, Childhood Obesity and other specialties. Pennington Biomedical Research Center is involved with conducting 301 clinical trials across 208 conditions. There are 10 research doctors associated with this hospital, such as Frank L Greenway, MD, Leanne M Redman, Ph.D., Eric Ravussin, PhD, and Daniel Hsia.Top PIs
Frank L Greenway, MDPennington Biomedical Research Center2 years of reported clinical research
Studies Obesity
Studies High Blood Pressure
7 reported clinical trials
9 drugs studied
Leanne M Redman, Ph.D.Pennington Biomedical Research Center4 years of reported clinical research
Studies Obesity
Studies Nutrition
5 reported clinical trials
5 drugs studied
Eric Ravussin, PhDPennington Biomedical Research Center3 years of reported clinical research
Studies Insulin Resistance
Studies Allergy
4 reported clinical trials
4 drugs studied
Daniel HsiaPennington Biomedical Research Center1 year of reported clinical research
Studies Obesity
2 reported clinical trials
3 drugs studied
Clinical Trials running at Pennington Biomedical Research Center
Obesity
Diabetes
Iron-Deficiency Anemia
Insulin Resistance
Type 2 Diabetes
Colorectal Cancer
Cachexia
Asthma
Insulin Sensitivity
Health Behaviors
Overfeeding Effects on Obesity
for undefined
Adipose, or fat, tissue is a plastic organ that retains the ability to expand and store excess calories during positive energy balance in humans. The capacity of subcutaneous (subQ) adipose tissue to expand and remodel is an important determinant of obesity-related health complications, and impaired expansion of subQ fat tissue is thought to contribute to the risk of diseases such as the Metabolic Syndrome (MetS) and type 2 diabetes mellitus (T2D). The objectives of the study are to evaluate the changes and mechanisms of (subQ) adipose tissue expandability that occur as a result of short-term weight gain and to investigate the effects on cardio-metabolic health outcomes. Findings from this study will provide new insight into the dynamics of adipose expansion and remodeling during changes in energy balance and how this may impact future fat tissue function and metabolic health.
Recruiting1 award N/A8 criteria
Orforglipron
for Obesity
This trial will test the safety and effectiveness of an oral medication called orforglipron in adults who are obese or overweight and have related health problems. The medication aims to help reduce body weight by possibly affecting appetite or metabolism.
Recruiting1 award Phase 34 criteria
Time-Restricted Eating
for Obesity and Insulin Resistance
The goal of this randomized controlled trial is to test the effect of time-restricted eating (14-hour fast, 10-hour eating window) of a low-energy dense diet (reduced calories per gram of food) in older adults with obesity and insulin resistance. The study aims to determine if modulating the energy density of the diet reduces: 1. Insulin resistance and 2. Body weight. Researchers will compare the groups: 1. Following time-restricted eating and given a diet reduced in energy density or 2. Following time-restricted eating and given a diet typically consumed in this population
Recruiting1 award N/A
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Pennington Biomedical Research Center?
Pennington Biomedical Research Center is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Obesity, Diabetes, Type 2 Diabetes, Insulin Resistance, Childhood Obesity and other specialties. Pennington Biomedical Research Center is involved with conducting 301 clinical trials across 208 conditions. There are 10 research doctors associated with this hospital, such as Frank L Greenway, MD, Leanne M Redman, Ph.D., Eric Ravussin, PhD, and Daniel Hsia.